The L’Oréal-UNESCO For Women in Science programme has announced its 2026 Singapore grantees, recognising th...
Illumina has announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a coho...
CellProthera, a clinical-stage company developing regenerative cell therapies for ischemic diseases, has announced its s...
Regenerative medicine is entering a defining phase as stem-cell research moves beyond laboratory discoveries towards cli...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Novartis ha...
Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral anti...
Clinical research has become increasingly global, yet an important distinction remains between conducting clinical trial...
AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...
Artificial intelligence is changing how researchers identify therapeutic targets and design molecules, but its lasting v...
GCCL, a South Korea-based leading global clinical trial central laboratory, has signed a Memorandum of Understanding (Mo...
Everest Medicines announced on June 26, 2026, that China’s National Medical Products Administration (NMPA) accepte...
Akeso has received clearance from the Center for Drug Evaluation under China’s National Medical Products Administr...
IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application o...
Sichuan Kelun-Biotech Biopharmaceutical has reported published Phase III results for trastuzumab botidotin in patients w...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial evaluating leriglitazo...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
Based at the Saw Swee Hock School of Public Health, National University of Singapore, ADVANCE-ID is Singapore’s 13...
Everest Medicines has received approval from China’s National Medical Products Administration for CARDAMYST, or et...
China Medical System Holdings has announced that its subsidiary Dermavon Holdings has received approval from China&rsquo...
DHL Group is expanding its life sciences and healthcare logistics infrastructure in Singapore through new and upgraded f...
FedEx is strengthening its healthcare and life sciences logistics network in Asia Pacific, with its Singapore Life Scien...
